NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE (MRD) MONITORING IN MANTLE CELL AND FOLLICULAR LYMPHOMA: THE TARGETED LOCUS AMPLIFICATION (TLA) NGS STRATEGY. (June 2017) - Ferrero, S.; Genuardi, E.; Klous, P.; Drandi, D.; Mantoan, B.; Monitillo, L.; Barbero, D.; Yilmaz, M.; Cattellino, F.; Vasta, M.; Cavallo, F.; Cortelazzo, S.; et al.